Mazindol ER is under clinical development by NLS Pharmaceutics and currently in Phase II for Narcolepsy. According to GlobalData, Phase II drugs for Narcolepsy have a 59% phase transition success rate ...

Pitolisant hydrochloride is under clinical development by Bioprojet SCR and currently in Phase II for Autism Spectrum Disorder (ASD).

The contact-free sleep monitoring systems market is projected to grow at an 8.1% CAGR, reaching $214.7 million by 2033 from ...

INR:8442. boylesports 30 free bet The only non-regulated narcolepsy drug! Wakix is ​​approved by the US FDA for a new indication 5500 down to 123, fou ...

INR:5660. delhi super satta company The salary increase for primary care doctors is coming, especially for these types of people BeiGene enters into col ...

INR:3960. dp boss net FDA approves innovative narcolepsy treatment Grifols acquires proteomics startup for $146 million CDE issues a trial notice on the working proce ...

Lack of sleep is an obvious energy drainer. Discover why you’re always so tired: Finding true rejuvenation beyond sleep: ...

Born in 1991, Lauren has faced significant health challenges, including a narcolepsy diagnosis in 2019. Lauren has shared her story on platforms such as NPR, Project Sleep’s Narcolepsy Nerd Alert ...

If this isn't enough to move the needle forward, the company has already initiated a phase 2a study using ORX750 to treat ...

Jazz's neuroscience franchise faces declining Xyrem sales but sees growth in Xywav and Epidiolex. Oncology growth is driven ...

Our most-read coverage from the 2024 SLEEP meeting included discussions about novel orexin agonists, associations between sleep and mental health, guideline updates, and influence of sleep health on ...

11, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced the publication of combined ...